Li-Ion Battery Aging & Durability Patent Landscape 2026
Contemporary Amperex Technology dominates a moderately concentrated field, holding the top two ranked positions among 1,697 patent families in scope. Activity peaked in 2022 and has since eased, with the United States the primary filing jurisdiction by a wide margin.
CATL entities lead a moderately concentrated field
Contemporary Amperex Technology (Hong Kong) Limited ranks first with 176 patent families, followed by Contemporary Amperex Technology Co Ltd at 100 patent families — meaning related CATL entities collectively anchor the top of the ranking. Medtronic Inc places third with 81 patent families, reflecting the importance of implantable-device battery longevity as a distinct application segment.
The top five filers account for 29% of the combined output of the hundred largest filers. That share indicates a moderately concentrated field: a meaningful lead group exists, but the remaining 95 ranked applicants collectively hold the majority of activity, leaving room for challengers to close ground on individual technology routes.
| # | Applicant | Patent families | Share |
|---|---|---|---|
| 1 | Contemporary Amperex Technology (Hong Kong) Limited | 176 | |
| 2 | Contemporary Amperex Technology Co., Ltd. | 100 | |
| 3 | Medtronic Inc. | 81 | |
| 4 | Zhuhai CosMX Battery Co., Ltd. | 67 | |
| 5 | Sila Nanotechnologies Inc. | 66 | |
| 6 | Robert Bosch GmbH | 56 | |
| 7 | Hydro-Québec | 46 | |
| 8 | A123 Systems LLC | 42 | |
| 9 | Boston Power Inc. | 40 | |
| 10 | Honeycomb Battery Co. | 38 |
| # | Applicant | Patent families | Share |
|---|---|---|---|
| 11 | GRST International Ltd. | 36 | |
| 12 | Ningde Amperex Technology Ltd. | 33 | |
| 13 | Regents of the University of California | 33 | |
| 14 | Shenzhen Capchem Technology Co., Ltd. | 30 | |
| 15 | Aspen Aerogels Inc. | 29 | |
| 16 | Beijing Easpring Material Technology Co., Ltd. | 29 | |
| 17 | BYD Co., Ltd. | 26 | |
| 18 | SVOLT Energy Technology Co., Ltd. | 23 | |
| 19 | BTR New Material Group Co., Ltd. | 23 | |
| 20 | Lnventus Power Inc. | 21 |
CATL’s dual-entity presence at the top signals aggressive portfolio-building across Hong Kong and mainland-China registration structures. Medtronic’s top-three placement underscores that medical-device battery durability is a major discrete segment within this landscape, not a niche.
Filing counts for 2024–2026 are under-counted due to standard patent-publication lags of 18–24 months; the apparent decline from 2022 onward should not be read as a real contraction until those cohorts fully publish. Longer-window growth, applicant concentration, and technology-route coverage are therefore more reliable signals than the latest-year bar alone.
Annual filings plateaued near a 2022 peak; electrode and cell chemistry dominates the technology mix
The filing trend and IPC composition together reveal a field that expanded rapidly from 2017 to 2022 and has since plateaued, with an overwhelming share of activity concentrated in core battery-cell classes and a set of adjacent branches that remain comparatively sparse.
Annual filing trend
Filings grew from 107 in 2017 to a peak of 282 in 2022 — a more than 2.6× increase — before easing to 249 in 2023 and 187 in 2024. The 2025 and 2026 tallies are sharply under-counted due to publication lag and should not be interpreted as a further decline. The multi-year window still reflects a 23% growth rate, consistent with a field that has expanded substantially but whose annual pace has plateaued near its 2022 high.
↗ Hover for values · click a bar to ask EurekaTechnology composition
H01M (Batteries, cells & fuel cells) accounts for the large majority of IPC records, confirming that aging and durability research is concentrated in electrochemical cell architecture and materials. Adjacent classes — C01B (inorganic compounds), C01G (metal compounds), H02J (power supply systems), G01R (electrical measurement), and B82Y (nanotechnology) — each carry materially fewer records, marking them as under-served branches relative to the dominant core.
↗ Hover for values · click a bar to ask EurekaHighly cited patent families surfaced by the query
Citation-heavy patent families returned by the query. Use this section as citation context, not as a curated list of the most topic-specific patents.
Data-driven Model for Lithium-ion Battery Capacity…
A method of using data-driven predictive modeling to predict and classify battery cells by lifetime is provided that includes collecting a training dataset by cycling battery cells between a voltage V1 and a voltage V2, continuously measuring battery cell voltage, current, can temperature, and internal resistance during cycling, generating a discharge… (excerpt from the patent abstract)
| # | Patent | Citations |
|---|---|---|
| 1 | Cathode materials for secondary (rechargeable) lit… | 1,119 |
| 2 | Cathode materials for secondary (rechargeable) lit… | 516 |
| 3 | Medical device having lithium-ion battery | 468 |
| 4 | Electrolyte additive and use thereof in lithium-io… | 246 |
| 5 | Data-driven Model for Lithium-ion Battery Capacity… | 199 |
| 6 | Cathode materials for secondary (rechargeable) lit… | 185 |
| 7 | Lithium-ion battery | 165 |
| 8 | Carbon materials metal/metal oxide nanoparticle co… | 155 |
Ranked by total forward citations. Citation counts favour older and broadly cited patent families, and broad or adjacent patents may appear when they match the search scope. Treat this section as citation context, not as a curated list of the most topic-specific patents. Some patent titles may be shown in their original, non-English language where an accurate translation could not be guaranteed.
What the competitive structure means for R&D investment decisions
Four structural observations — maturity, concentration, collaboration, and geography — each carry distinct implications for teams deciding where to file, partner, or focus next-generation research.
Field has plateaued near its 2022 peak
The lifecycle stage is assessed as Maturity: annual filings have plateaued near their 2022 peak of 282, and the multi-year window still shows positive growth of 23%. This pattern suggests that the core design space is increasingly well-staked, making freedom-to-operate analysis more important and incremental differentiation harder. Teams entering now should target adjacencies rather than rediscovering well-claimed ground.
Mature / PlateauedTop five hold 29% of the hundred largest filers’ output
With the top five filers accounting for 29% of the hundred largest filers’ combined patent families, the field is moderately — not heavily — concentrated. A second tier of challengers (Zhuhai CosMX, Sila Nanotechnologies, Robert Bosch, Hydro-Québec) each hold between 46 and 67 patent families, suggesting the gap between leader and mid-tier is closable on specific sub-routes. Niche entrants can still build defensible positions in under-served branches.
Moderate ConcentrationSila Nanotechnologies–Georgia Tech is the most active co-filing pair
The most active co-applicant relationship is Sila Nanotechnologies and Georgia Tech Research Corporation, with four jointly filed patent families — the only pair in the collaboration record reaching that count. Secondary co-filing pairs include Zhuhai CosMX Battery with Zhuhai Guanqi New Materials (one family), Sila Nanotechnologies with Battelle Memorial Institute (one family), and Robert Bosch GmbH (Germany) with Robert Bosch Battery Systems (one family). The overall co-filing network is sparse, indicating that most R&D is conducted within single organizational boundaries.
Limited Co-filingUS leads filing activity; EPO and PCT cover international protection
The United States is by far the primary filing office, followed by Europe (EPO) and WIPO (PCT). India ranks fourth, ahead of China — an atypical distribution suggesting that US-originated filers dominate the corpus. China’s relatively low count may reflect domestic filers choosing to publish through Hong Kong or international routes. Teams targeting EV and consumer-electronics markets in Asia should evaluate whether their coverage in Chinese and Korean jurisdictions is sufficient given South Korea’s low recorded count.
US-Centric CoverageGo beyond the landscape: Eureka’s TRIZ Solution agent breaks down an R&D problem and returns patented concept solutions, each with a technical approach and cited patent & literature evidence.
| Applicant | Collaborator | Co-filings |
|---|---|---|
| Sila Nanotechnologies Inc. | Georgia Tech Research Corporation | 4 |
| Zhuhai CosMX Battery Co., Ltd. | Zhuhai Guanqi New Materials Co., Ltd. | 1 |
| Sila Nanotechnologies Inc. | Battelle Memorial Institute | 1 |
| Robert Bosch GmbH | Robert Bosch Battery Systems GmbH | 1 |
Co-filing pairs, ranked by the number of jointly-filed patent families.
CATL entities lead; Sila Nanotechnologies is the fastest-growing challenger
The ranking is shaped by two distinct organizational types: large battery manufacturers pursuing full-cell durability, and specialized materials or medical-device companies targeting specific aging mechanisms. Momentum data highlight which players are accelerating versus consolidating.
Contemporary Amperex Technology Co Ltd
The CATL group holds the top two positions in the ranking: the Hong Kong entity leads with 176 patent families and the mainland entity follows at 100 patent families. Both entities focus squarely on H01M 10 and H01M 4 — core battery-cell and electrode classes — reflecting a comprehensive cell-durability strategy. The Hong Kong entity’s recent-period trend shows a decline of 33%, while the mainland entity shows a steeper decline of 71% in recent filings, suggesting a possible consolidation of filing activity or a shift in registration strategy rather than a genuine pullback in R&D.
patent families: 176 + 100Sila Nanotechnologies Inc
Sila Nanotechnologies ranks fifth overall with 66 patent families and is the fastest-growing major challenger, with recent filings up 81% versus the prior period. Its technology emphasis covers H01M 10 and H01M 4, with notable activity in electrode materials — consistent with its silicon-anode focus aimed at improving cycle life and energy retention. Its co-filing relationship with Georgia Tech Research Corporation (four joint families) and with Battelle Memorial Institute adds an academic and national-lab dimension to its portfolio.
patent families: 66| Applicant | Recent (3 yrs) | Trend |
|---|---|---|
| Contemporary Amperex Technology Co., Ltd. (CATL) | 44 | ▼ -71% |
| Zhuhai CosMX Battery Co., Ltd. | 31 | ▲ +29% |
| Sila Nanotechnologies Inc. | 38 | ▲ +81% |
| A123 Systems LLC | 5 | ▲ new entrant |
| Contemporary Amperex Technology (Hong Kong) Limited | 10 | ▼ -33% |
| Shenzhen Capchem Technology Co., Ltd. | 22 | ▲ new entrant |
Under-served branches adjacent to the dominant H01M core
Four IPC classes sit at materially lower record counts than H01M, each with plausible technical relevance to aging and durability. Two stand out for their combination of relative sparsity and clear entry paths.
G01R · Electric & magnetic measurement for aging diagnostics
G01R carries 58 patent records — roughly 2% of the IPC distribution — despite the fact that in-situ electrical measurement is a core enabler of battery state-of-health estimation and degradation detection. Capacity-fade and impedance-spectroscopy methods for real-time aging characterization are technically adjacent to the dominant H01M core and are underrepresented here. Teams with sensing or signal-processing expertise could build a distinct position by filing degradation-detection methods under G01R alongside companion H01M claims, addressing a gap that incumbent battery manufacturers appear not to have fully staked.
Search this in Eureka →B82Y · Nanotechnology applications for cycle-life improvement
B82Y (Nanotechnology applications) accounts for 47 patent records — approximately 1% of the distribution — even though nano-structured electrode materials and nano-coatings are widely cited in academic literature as a means to suppress capacity fade and mechanical degradation. The sparse record count relative to the underlying scientific activity suggests this cross-sectional class is under-utilized by filers, not that the technology is absent. Entrants combining nano-material synthesis claims (C01B or C01G, themselves also relatively sparse at 195 and 126 records respectively) with B82Y cross-referencing may find a less-crowded claim space than the H01M core offers.
Search this in Eureka →How leading filers differ by technology route
Route coverage across the main technology branches in the current evidence set.
| Player | H01M 10 · Batteries, cells & fuel cells | H01M 4 · Batteries, cells & fuel cells | H01M 50 · Batteries, cells & fuel cells | H01M 2 · Batteries, cells & fuel cells | H02J 7 · Power supply & grid systems |
|---|---|---|---|---|---|
| Contemporary Amperex Technology Co., Ltd. (CATL) | Strong · 245 | Strong · 167 | Emerging · 18 | Emerging · 6 | Emerging · 4 |
| Medtronic Inc. | Strong · 80 | Strong · 79 | Moderate · 18 | Emerging · 7 | Absent |
| Zhuhai CosMX Battery Co., Ltd. | Strong · 67 | Strong · 56 | Moderate · 16 | Absent | Absent |
| Sila Nanotechnologies Inc. | Strong · 66 | Strong · 51 | Emerging · 11 | Absent | Absent |
| Robert Bosch GmbH | Strong · 51 | Strong · 31 | Emerging · 10 | Emerging · 10 | Emerging · 5 |
| Boston Power Inc. | Strong · 39 | Strong · 29 | Moderate · 9 | Moderate · 16 | Absent |
| GRST International Ltd. | Strong · 36 | Strong · 34 | Moderate · 11 | Emerging · 7 | Absent |
Frequently asked questions
The analysis covers 1,697 patent families. The United States is the leading filing jurisdiction, and the corpus spans from 2017 through 2026, though the most recent 18–24 months are under-counted due to publication lag.
Contemporary Amperex Technology (Hong Kong) Limited leads with 176 patent families, followed by its related entity Contemporary Amperex Technology Co Ltd at 100 patent families. Together the two CATL-affiliated entities are the dominant force in the ranking.
Medtronic Inc ranks third with 81 patent families because implantable medical devices — pacemakers, defibrillators, neurostimulators — impose extreme longevity requirements on their lithium-ion cells. Battery aging and durability are safety-critical concerns in that application, making Medtronic a major and distinct contributor to this patent space.
The field is assessed as Maturity. Annual filings peaked at 282 in 2022 and have since plateaued. The multi-year growth rate remains positive at 23%, indicating the field is still expanding on a cumulative basis, but the rate of new annual filings has eased from its 2022 high.
Sila Nanotechnologies Inc shows the strongest momentum among established ranked filers, with recent-period filings up 81% versus the prior period. Shenzhen Capchem Technology and A123 Systems are recorded as new entrants in the recent window, though their absolute recent counts are smaller.
The sparsest adjacent branches relative to the dominant H01M core are B82Y (Nanotechnology applications, 47 records), G01R (Electric & magnetic measurement, 58 records), H02J (Power supply & grid systems, 103 records), C01G (Compounds of other metals, 126 records), and C01B (Non-metallic elements & inorganic compounds, 195 records). G01R and B82Y are particularly under-served given their direct technical relevance to degradation detection and nano-material cycle-life improvement.
Built on Patsnap Open Platform
This report’s underlying patent dataset — filings, assignees, technology clusters — is open for developers via MCP and REST API. Free to start, 10,000 credits, no credit card required.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.